SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001640334-18-001822
Filing Date
2018-09-26
Accepted
2018-09-26 17:31:19
Documents
18

Document Format Files

Seq Description Document Type Size
1 FORM S-1 AMENDMENT NO. 1 inmune_s1a1.htm S-1/A 1285305
2 EX-1.1 inmune_ex11.htm EX-1.1 167714
3 EX-4.1 immune_ex41.htm EX-4.1 1756
4 EX-4.2 inmune_ex42.htm EX-4.2 47207
5 EX-10.21 inmune_ex1021.htm EX-10.2 3501
6 EX-10.22 inmune_ex1022.htm EX-10.21 39070
7 EX-23.2 inmune_ex232.htm EX-23.2 1676
9 immune_ex41img2.jpg GRAPHIC 794701
10 immune_ex41img5.jpg GRAPHIC 431189
11 inmune_correspimg1.jpg GRAPHIC 8210
12 inmune_s1img1.jpg GRAPHIC 6991
13 inmune_s1img10.jpg GRAPHIC 66249
14 inmune_s1img11.jpg GRAPHIC 109210
15 inmune_s1img12.jpg GRAPHIC 59233
16 inmune_s1img13.jpg GRAPHIC 79478
17 inmune_s1img14.jpg GRAPHIC 71885
18 inmune_s1img9.jpg GRAPHIC 56277
19 filename19.htm CORRESP 11154
  Complete submission text file 0001640334-18-001822.txt   3878494
Mailing Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037
Business Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-227122 | Film No.: 181088727
SIC: 2836 Biological Products, (No Diagnostic Substances)